Brevetti EPO No.3256125 2022.01.26
Brevetti EPO
(10) Registration Number and Date
2022000137 2022.03.24
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2022/000137 2015.12.10
(40) Publication Number and Date
SM /T/2022/000137 2022.03.24
(30) Priority Details
WO PCT/EP2014/077469
2014.12.11
WO PCT/EP2015/058202
2015.04.15
(51) IPC Classes
(72) Inventor
(IT) DINGEMANSE, Jasper : c/o Actelion Pharmaceuticals LtdGewerbestrasse 16, 4123 Allschwil, CH
(IT) HOCH, Matthias : 22 Orchard CloseHarston, CambridgeCambridgeshire CB22 7PT, GB
(IT) KRAUSE, Andreas : c/o Actelion Pharmaceuticals LtdGewerbestrasse 16, 4123 Allschwil, CH
(74) Representative Name
(IT) DE BENEDETTI, Jacopo : Via L. Cibrario, 25, 47893 Borgo Maggiore RSM , SM
(54) Title
(IT) REGIME DI DOSAGGIO PER PONESIMOD, UN AGONISTA DEL RECETTORE S1P1 SELETTIVO
(EN) DOSING REGIMEN FOR PONESIMOD, A SELECTIVE S1P1 RECEPTOR AGONIST
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2022.05.18
Event NameDateStatus
Filing2015.12.10Filed
Brevetto EPO concesso2022.03.24Published
Ricevuta pagamento annualita 82022.11.30Payed
Ricevuta pagamento annualita 92023.12.01Payed
Ricevuta pagamento annualita 102024.12.19Payed